Seoul National University Hospital: Schizophrenia trials

The registry lists 17 Schizophrenia studies with Seoul National University Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 4 4No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of tDCS on Schizophrenia With Negative SymptomsWithdrawnNCT03729791Not applicable
• Therapeutic Drug Monitoring for Individualized Clozapine TherapyStatus unknownNCT03523741
• Predicting Antipsychotic Discontinuation in PsychosisStatus unknownNCT02884518Not applicable
• [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in PsychosisStatus unknownNCT02880995Not applicable
• Treatment of Refractory Auditory Verbal Hallucinations With tDCS in SchizophreniaCompletedNCT02451371Phase 1/2
• Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in SchizophreniaCompletedNCT02248987
• Stem Cell Research on Subjects at Genetic High Risk for SchizophreniaCompletedNCT01943175
• The Effect of Paliperidone Palmitate in SchizophreniaCompletedNCT01860781Phase 4
• Antipsychotic Discontinuation in High-risk SubjectsWithdrawnNCT01758887
• Switching From Consta® to Sustenna® in Patients With SchizophreniaCompletedNCT01698216
• Validation of Receptor Occupancy SimulationCompletedNCT01660880
• The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking ClozapineTerminatedNCT01654640Phase 4
• Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia PatientsCompletedNCT01399450Phase 4
• Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics MedicationStatus unknownNCT00698295
• Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar DisordersStatus unknownNCT00330226
• Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With SchizophreniaCompletedNCT00328952
• Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory SchizophreniaCompletedNCT00328367Phase 4